Prognostic Risk Stratification and Clinical Outcomes in Patients Undergoing Surgical Treatment for Renal Cell Carcinoma with Vascular Tumor Thrombus
- 30 June 2007
- journal article
- Published by Elsevier BV in Urology
- Vol. 69 (6), 1054-1058
- https://doi.org/10.1016/j.urology.2007.02.052
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- The Mayo Clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombusBJU International, 2004
- Prognostic Significance of Venous Thrombus in Renal Cell Carcinoma. Are Renal Vein and Inferior Vena Cava Involvement Different?Journal of Urology, 2004
- Prognostic Significance of Tumor Thrombus Level in Patients With Renal Cell Carcinoma and Venous Tumor Thrombus Extension. Is All T3b the Same?Journal of Urology, 2004
- Surgical management of renal cell carcinoma with inferior vena cava tumor thrombusThe American Journal of Surgery, 2002
- METASTATIC RENAL CELL CARCINOMA WITH CONCURRENT INFERIOR VENA CAVAL INVASION: LONG-TERM SURVIVAL AFTER COMBINATION THERAPY WITH RADICAL NEPHRECTOMY, VENA CAVAL THROMBECTOMY AND POSTOPERATIVE IMMUNOTHERAPYJournal of Urology, 1999
- Treatment of Metastatic Renal Cell Carcinoma With Nephrectomy, Interleukin-2 and Cytokine-Primed or CD8(+) Selected Tumor Infiltrating Lymphocytes from Primary TumorJournal of Urology, 1997
- Long-Term Followup After Surgical Treatment for Renal Cell Carcinoma Extending into the Right AtriumJournal of Urology, 1996
- Radical nephrectomy in patients with renal cell carcinoma with venous, vena caval, and atrial extensionThe American Journal of Surgery, 1994
- Nephrectomy for metastatic renal cell carcinoma: A component of systemic treatment regimensJournal of Surgical Oncology, 1994
- A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 AloneNew England Journal of Medicine, 1987